Skip to main content
Premium Trial:

Request an Annual Quote

Quebec Starts Genomic Databank for Blood Transfusion Safety

NEW YORK (GenomeWeb News) – Two Canadian non-profit organizations in Québec announced this week that they have created a permanent database of genomic information of about 22,000 blood donors in order to help make transfusions safe for patients in the province.
 
The partners, Héma-Québec and Génome Québec, have created a database that will help locate compatible blood more easily for patients who are in need of transfusions of specific blood profiles.
 
Genome Québec provided the genotyping to develop the platform, and the project included the efforts of the Montreal Heart Institute Pharmacogenomics Center.
 
“Working with Génome Québec enabled us develop this technology much more quickly by acceding to extensive expertise in high throughput automated genotyping and to the necessary equipment,” said Héma-Québec President and CEO Francine Décary.
 

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.